Weed Inc. in brief
Weed Inc. is a listed company in the Pharmaceutical industry, based in Tucson, Arizona, USA. Its last known market value was $9 M (July 2023); there is no current figure.
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Weed Inc.
We were originally incorporated under the name Plae, Inc., in the State of Arizona on August 20, 1999. At the time we operated under the name Plae, Inc., no business was conducted. No books or records were maintained and no meetings were held. In essence, nothing was done after incorporation until Glenn E. Martin took possession of Plae, Inc. in January 2005. On February 18, 2005, the corporate name was changed to King Mines, Inc. and then subsequently changed to its current name, United Mines, Inc., on March 30, 2005. No shares were issued until the Company became United Mines, Inc. From 2005 until 2015, we were an exploration stage mineral exploration company that owned a number of unpatented BLM mining claims and Arizona State Land Department exploration leases.
From the company's annual report filed with the US SEC: read the report
Weed Inc. timeline
- 2007
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2014
- ✎Renamed Weed, Inc.Formerly United Mines Inc.
Events of Weed Inc. from SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #5,158 (Jan 2022) · #5,458 (Jul 2023)
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | — | — | $-1M | $-1M | — |
| Dec 2024 | — | — | $-1M | $-1M | — |
| Dec 2023 | — | — | $-1M | $-0M | — |
| Dec 2022 | — | — | $-2M | $-2M | — |
| Dec 2021 | — | — | $-3M | $-3M | — |
| Dec 2020 | — | — | $-4M | $-4M | — |
| Dec 2019 | — | — | $-27M | $-28M | — |
| Dec 2018 | — | — | $-28M | $-29M | — |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $-0M | — | — | $-0.01 | — |
| Dec 2024 | $-0M | — | — | $-0.00 | — |
| Dec 2023 | $-1M | $0M | $-1M | $-0.00 | — |
| Dec 2022 | $-1M | $0M | $-1M | — | — |
| Dec 2021 | $-1M | $0M | $-1M | $-0.02 | — |
| Dec 2020 | $-0M | $0M | $-0M | $-0.04 | — |
| Dec 2019 | $-1M | $0M | $-1M | $-0.26 | — |
| Dec 2018 | $-3M | $1M | $-4M | $-0.28 | — |
Quarterly results
Latest quarter to Jun 2026: revenue —, net income $-0M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Jun 2026.
SEC filings
- Aug 14, 202610-QQuarterly report · period to Jun 2026
- May 15, 202610-QQuarterly report · period to Mar 2026
- Apr 8, 202610-KAnnual report · period to Dec 2025
- Dec 29, 202510-Q/AQuarterly report (amended) · period to Sep 2025
- Dec 23, 202510-QQuarterly report · period to Sep 2025
- Aug 14, 202510-QQuarterly report · period to Jun 2025
- May 15, 202510-QQuarterly report · period to Mar 2025
- Mar 31, 202510-KAnnual report · period to Dec 2024
- Nov 14, 202410-QQuarterly report · period to Sep 2024
- Aug 14, 202410-QQuarterly report · period to Jun 2024
- May 15, 202410-QQuarterly report · period to Mar 2024
- Apr 1, 202410-KAnnual report · period to Dec 2023
Official filings of Weed Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- —
- Operating income
- $-1 M
- Net income
- $-1 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $1 M
- Total liabilities
- $1 M
- Total equity
- $-1 M
As of December-2025
Insider trading at Weed Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Nicole M. BreenSecretary and Treasurer, Director, 10% owner | Sellindirect | -60,000 | $0.030 | $2 K | 29.75 M | Form 4 |
| filed | Nicole M. BreenSecretary and Treasurer, Director, 10% owner | Sellindirect | -10,000 | $0.030 | $300 | 29.81 M | Form 4 |
| filed | Nicole M. BreenSecretary and Treasurer, Director, 10% owner | Sellindirect | -50,000 | $0.030 | $2 K | 29.82 M | Form 4 |
| filed | Nicole M. BreenSecretary and Treasurer, Director, 10% owner | Sellindirect | -50,000 | $0.030 | $2 K | 29.87 M | Form 4 |
| filed | Nicole M. BreenSecretary and Treasurer, Director, 10% owner | Sellindirect | -80,000 | $0.250 | $20 K | 29.92 M | Form 4 |
| filed | Nicole M. BreenSecretary and Treasurer, Director, 10% owner | Sellindirect | -50,000 | $0.030 | $2 K | 30.00 M | Form 4 |
| filed | Nicole M. BreenSecretary and Treasurer, Director, 10% owner | Sellindirect | -50,000 | $0.030 | $2 K | 30.05 M | Form 4 |
| filed | Nicole M. BreenSecretary and Treasurer, Director, 10% owner | Sellindirect | -5,008 | $0.040 | $200 | 30.10 M | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Weed Inc. scorecard#
Passes 1 of the 7 checks that could be worked out. Fiscal year 2025.
Valuationnot known
- –P/E below its peers' medianNo market cap.
- –Price to book below its peers' medianNo market cap.
- –Price to sales below its peers' medianNo market cap.
- –Free cash flow yield above 5%No market cap.
- –Earnings yield above the 10-year Treasury yieldNo market cap.
- –The price assumes slower growth than the last three years'No market cap.
Growth1 of 2
- –Revenue grew in the newest yearRevenue of the year before is not on file.
- –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
- –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
- ✗Earnings per share grew in the newest year-0.01 vs -0.00Diluted EPS -0.01 in fiscal 2025 against -0.00 the year before (report's currency).
- ✓Net income higher than five years earlier-$1 M-$1 M in fiscal 2025 against -$4 M in 2020.
- –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
Profitability0 of 2
- ✗Profitable in the newest year-$1 MNet income -$1 M in fiscal 2025.
- ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
- –Operating margin above its peers' medianNo operating margin on file.
- –Return on equity above 15%No return on equity (equity missing or negative).
- –Return on invested capital above 10%No return on invested capital on file.
- –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
Financial health0 of 2
- ✗Short-term assets cover short-term liabilities0.0×Current ratio 0.04 at the end of fiscal 2025.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
- –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
Shareholder returns0 of 1
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year9.5%Diluted shares up 9.5% in fiscal 2025.
- –Dividends and buybacks above 3% of the market valueNo market cap.
- –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.
Worked out from the statements as filed (sec), the medians of Pharmaceutical, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Weed Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 | FY 2019to Dec 31, 2019 | FY 2018to Dec 31, 2018 | FY 2017to Dec 31, 2017 | FY 2011to Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| Revenue | 0—— | 0—— | 0—— | 0—— | — | 0—— | 0—— | 0—— | 0—— | 0—— | |
| Cost of revenue | 0—— | 0—— | 0—— | 0—— | — | — | — | — | — | — | |
| Gross profit | 0—— | 0—— | 0—— | 0—— | — | — | — | — | — | — | |
| Selling and marketing | — | — | — | — | — | — | — | — | — | 13—— | |
| General and administrative | 1,128+221%— | 351−11.0%— | 395−30.4%— | 567−28.9%— | 798+154%— | 314−67.6%— | 970−28.6%— | 1,358r1,037+102%— | 672—— | 2,043—— | |
| Operating expenses | 1,328+151%— | 530−31.2%— | 771−48.8%— | 1,505−46.3%— | 2,801−31.3%— | 4,076−85.1%— | 27,417−3.5%— | 28,406r28,084+1091%— | 2,384—— | 2,087—— | |
| Operating income | −1,328—— | −530—— | −771—— | −1,505—— | −2,801—— | −4,076—— | −27,417—— | −28,406r−28,084—— | −2,384—— | 2,087—— | |
| Interest expense and finance costs | — | 5.1−88.8%— | 45r45−61.3%— | 117+198%— | 39−3.9%— | 41+250%— | 12−4.2%— | 12−12.2%— | 14—— | −3.5—— | |
| Other non-operating income (expense) | −44—— | −50−107%— | 740—— | −23—— | −40−455%— | 11—— | −113—— | −909r−1,231—— | −1,098—— | 3.5—— | |
| Income before tax | −1,372—— | −510—— | — | −1,528—— | −2,842—— | −4,065—— | — | — | — | — | |
| Income tax | 0.0−91.7%— | 0.4−59.3%— | 1.0—— | 0—— | — | — | — | — | — | — | |
| Net income including minority interests | — | −511—— | −32—— | −1,528—— | — | — | — | — | — | — | |
| Net income attributable to shareholders | −1,372—— | −511—— | −32—— | −1,528—— | −2,842—— | −4,065—— | −27,530—— | −29,315—— | −3,482—— | 2,090—— | |
| Earnings per share, basic | — | -0.00—— | -0.00—— | -0.01—— | -0.02—— | -0.04—— | -0.26r0.26—— | -0.28—— | -0.03—— | -0.17—— | |
| Earnings per share, diluted | -0.01—— | -0.00—— | -0.00—— | — | -0.02—— | -0.04—— | -0.26r0.26—— | -0.28—— | -0.03—— | -0.17—— | |
| Shares, weighted average (basic) | — | 124+0.3%— | 124+1.3%— | 122+4.6%— | 117—— | — | — | — | — | — | |
| Shares, weighted average (diluted) | 136+9.5%— | 124+0.3%— | 124—— | — | 117+4.0%— | 112+4.2%— | 108+4.3%— | 103+1.9%— | 101—— | 12—— | |
| Balance sheet | |||||||||||
| Cash and cash equivalents | 33−79.2%5.9% | 159−45.1%21.6% | 290−8.0%32.1% | 316+1507%19.3% | 20+55.6%1.0% | 13+403%0.7% | 2.5−96.4%0.1% | 71−56.2%2.3% | 161—12.3% | 0.0—0.0% | |
| Receivables | — | — | — | — | 0.80.0%0.0% | 0.80.0%0.0% | 0.8+3814%0.0% | 0.0—0.0% | 0—0.0% | — | |
| Other current assets | 3.9−4.0%0.7% | 4.1−16.5%0.5% | 4.9+199%0.5% | 1.6+97.4%0.1% | 0.8—0.0% | — | — | — | — | — | |
| Current assets | 48−74.9%8.5% | 190−40.6%25.7% | 320−6.5%35.4% | 342+716%20.9% | 42−83.6%2.1% | 255+102%14.0% | 126−74.3%6.5% | 492+153%16.3% | 194—14.8% | 3.4—2.5% | |
| Property, plant and equipment | 476−4.0%85.1% | 496−3.9%67.2% | 516−57.3%57.1% | 1,209−35.6%74.0% | 1,877+23.4%95.8% | 1,521−14.6%83.6% | 1,780−28.2%91.2% | 2,481r2,344+148%82.1% | 1,000—76.5% | 17—13.2% | |
| Right-of-use (leased) assets | 4.8−74.4%0.8% | 19−41.4%2.5% | 32−28.3%3.5% | 44—2.7% | — | — | — | — | — | — | |
| Goodwill | — | — | 0—0.0% | 0—0.0% | 0—0.0% | — | — | — | — | — | |
| Other intangible assets | 31−7.7%5.5% | 34—4.5% | — | — | 41−5.9%2.1% | 43−6.1%2.4% | 46−5.4%2.4% | 49—1.6% | 0—0.0% | — | |
| Total assets | 560−24.2%100% | 738−18.3%100% | 904−44.7%100% | 1,634−16.6%100% | 1,959+7.7%100% | 1,819−6.8%100% | 1,953−35.4%100% | 3,021+131%100% | 1,308—100% | 132—100% | |
| Accounts payable | 180+7.4%32.1% | 168−8.7%22.7% | 184−3.3%20.3% | 190−22.8%11.6% | 246+1.6%12.5% | 242+14.0%13.3% | 212−11.8%10.9% | 240+5.2%8.0% | 229—17.5% | 63—47.3% | |
| Current liabilities | 1,248+30.1%223% | 959+47.9%130% | 649−55.7%71.8% | 1,464+9.1%89.6% | 1,342+43.2%68.5% | 937+24.5%51.5% | 753+190%38.6% | 259−72.6%8.6% | 948—72.5% | 243—184% | |
| Total liabilities | 1,248+30.1%223% | 959+47.9%130% | 649−55.7%71.8% | 1,464+9.1%89.6% | 1,342+43.2%68.5% | 937+24.5%51.5% | 753+190%38.6% | 259−72.6%8.6% | 948—72.5% | 243—184% | |
| Retained earnings | −86,275—−15409% | −84,903—−11499% | −84,393—−9335% | −84,361—−5163% | −82,833—−4228% | −79,991—−4398% | −75,926—−3888% | −48,396—−1602% | −19,081—−1458% | −7,181—−5429% | |
| Shareholders' equity | −688—−123% | −221−187%−29.9% | 255+50.4%28.2% | 170−72.5%10.4% | 618−30.0%31.5% | 882−26.5%48.5% | 1,200−56.6%61.4% | 2,762+667%91.4% | 360—27.5% | −111—−83.8% | |
| Total liabilities and equity | 560−24.2%100% | 738−18.3%100% | 904−44.7%100% | 1,634−16.6%100% | 1,959+7.7%100% | 1,819−6.8%100% | 1,953−35.4%100% | 3,021+131%100% | 1,308—100% | 132—100% | |
| Shares outstanding | 147+17.5%— | 125+1.6%— | 1230.0%— | 123+3.6%— | 119r119+5.2%— | 113+3.8%— | 109+3.1%— | 106+5.0%— | 101—— | 14—— | |
| Cash-flow statement | |||||||||||
| Depreciation and amortization | 22−0.4%— | 23−56.9%— | 52−53.0%— | 111−14.1%— | 130−11.0%— | 146−8.5%— | 159−11.7%— | 181+305%— | 45—— | 1.8—— | |
| Share-based compensation | 800+3900%— | 20—— | — | — | 2,003−0.6%— | 2,016−91.1%— | 22,771+7.4%— | 21,201—— | 0—— | 1,877—— | |
| Cash from operating activities | −195—— | −416—— | −1,074—— | −813—— | −569—— | −431—— | −1,111—— | −3,181—— | −670—— | −124—— | |
| Capital expenditure | — | — | −10—— | 0—— | −271—— | 0—— | −3.0—— | −826—— | −535—— | 0—— | |
| Intangible assets bought | — | — | — | — | — | 0—— | 0—— | −50—— | 0—— | 0—— | |
| Cash from investing activities | — | — | 1,631+29.8%— | 1,257—— | −271−266%— | 164—— | −3.0—— | −876—— | −535—— | 0—— | |
| Shares issued | — | — | 0−100%— | 40—— | — | — | — | — | — | 110—— | |
| Cash from financing activities | 70−75.4%— | 285—— | −588—— | −149−118%— | 849+206%— | 277−73.5%— | 1,046−73.6%— | 3,967+190%— | 1,366—— | 123—— | |
| Exchange-rate effect on cash | −1.2—— | −0.8—— | — | — | −1.4−396%— | 0.5—— | −0.6—— | — | — | — | |
| Change in cash | — | −130—— | −31−110%— | 295+3388%— | 8.5−12.1%— | 9.6—— | −67—— | −91−156%— | 161—— | −1.1—— | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Jun 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 | Q3 FY2023to Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 0—— | 0—— | 0—— | 0*—— | 0—— | 0—— | 0—— | 0*—— | 0—— | 0—— | 0—— | 0*—— | 0—— | |
| Cost of revenue | — | 0—— | 0—— | — | — | 0—— | 0—— | — | — | — | 0—— | — | — | |
| Gross profit | — | 0—— | 0—— | — | — | 0—— | 0—— | — | — | — | 0—— | — | — | |
| General and administrative | 823+42.8%— | 75+16.7%— | 68−82.3%— | 622*+866%— | 59−9.7%— | 64−24.9%— | 383+181%— | 64*−49.2%— | 65+156%— | 85—— | 137—— | 127*—— | 25—— | |
| Operating expenses | 1,049+40.0%— | 91−3.3%— | 164−62.3%— | 727*+470%— | 67−27.8%— | 94−35.1%— | 435+160%— | 127*−33.5%— | 93−61.2%— | 145—— | 167r170—— | 192*—— | 239—— | |
| Operating income | −1,049—— | −91—— | −164—— | −727*—— | −67—— | −94—— | −435—— | −127*—— | −93—— | −145—— | −167r−170—— | −33r−192*—— | −239—— | |
| Interest expense and finance costs | — | 13−2.6%— | — | — | — | 14+2166%— | 5.7+855%— | — | 3.2−78.8%— | 0.6—— | 0.6—— | — | 15—— | |
| Other non-operating income (expense) | −55—— | −13—— | −11—— | −23*—— | −7.0—— | −14−139%— | −5.7—— | −5.8r9.6*—— | −3.2−100%— | 34—— | −3.2r−0.6—— | −1,146r−203*—— | 973—— | |
| Income before tax | −1,103—— | −104—— | −175—— | −750*—— | −74—— | −108—— | −440—— | −133*—— | −96—— | −111—— | — | — | — | |
| Income tax | 0.0—— | 0—— | 0—— | 0*—— | 0.0—— | 0−100%— | 0—— | 0*—— | 0—— | 0.4—— | 0—— | — | — | |
| Net income including minority interests | — | −104—— | −175—— | — | −74*—— | −108—— | −440−221%— | −133*—— | −96−113%— | −111—— | 364r−171—— | −395*—— | 734—— | |
| Net income attributable to shareholders | −1,104—— | −104—— | −175—— | −750*—— | −74—— | −108—— | −440r−440—— | −133r−133—— | −96−113%— | −111—— | −171—— | −395—— | 734—— | |
| Earnings per share, basic | — | — | — | — | — | — | — | — | — | — | — | — | 0.01—— | |
| Earnings per share, diluted | — | -0.00—— | -0.00—— | — | -0.00—— | -0.00—— | -0.00—— | — | -0.00—— | -0.00—— | -0.00—— | — | — | |
| Shares, weighted average (basic) | — | — | — | — | — | — | — | — | — | — | — | — | 123—— | |
| Shares, weighted average (diluted) | 148+9.1%— | 148+9.1%— | 148+11.4%— | — | 136+7.3%— | 136+7.7%— | 132r133+7.0%— | — | 127—— | 126—— | 124—— | — | — | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 1.1—0.2% | 1.1−80.1%0.2% | 1.8−42.9%0.3% | 33−79.2%5.9% | 0.4−92.5%0.1% | 5.4−68.1%1.0% | 3.1−96.9%0.5% | 159−45.1%21.6% | 5.3−99.2%0.9% | 17r15—2.8% | 103—14.6% | 290—32.1% | 644—50.5% | |
| Other current assets | 3.9—0.8% | 3.9−14.1%0.8% | 3.9−3.2%0.8% | 3.9−4.0%0.7% | 4.5+3.3%0.9% | 4.5+9.7%0.8% | 4.0−9.4%0.7% | 4.1−16.5%0.5% | 4.4−63.5%0.7% | 4.1—0.7% | 4.4—0.6% | 4.9—0.5% | 12—0.9% | |
| Current assets | 7.6—1.5% | 7.6−58.7%1.5% | 12−65.3%2.4% | 48−74.9%8.5% | 11−72.2%2.1% | 18−50.0%3.4% | 36−72.3%6.2% | 190−40.6%25.7% | 39−94.2%6.6% | 37—6.1% | 129—18.3% | 320—35.4% | 684—53.6% | |
| Property, plant and equipment | 467—92.6% | 467−4.1%92.6% | 471−4.0%91.4% | 476−4.0%85.1% | 481−4.0%90.5% | 486−3.9%88.6% | 491−3.9%85.4% | 496−3.9%67.2% | 501−3.6%84.0% | 506—83.9% | 511—72.6% | 516—57.1% | 520—40.8% | |
| Right-of-use (leased) assets | 0—0.0% | 0−100%0.0% | 1.5−90.0%0.3% | 4.8−74.4%0.8% | 8.3−62.2%1.6% | 12−53.4%2.1% | 15−46.7%2.6% | 19−41.4%2.5% | 22−37.2%3.7% | 25—4.2% | 28—4.0% | 32—3.5% | 35—2.7% | |
| Goodwill | — | — | — | — | — | — | — | — | — | — | — | 0—0.0% | 0—0.0% | |
| Other intangible assets | 30—5.9% | 30—5.9% | 30—5.9% | 31−7.7%5.5% | 32—5.9% | — | — | 34—4.5% | — | — | — | — | — | |
| Total assets | 504—100% | 504−8.2%100% | 516−10.3%100% | 560−24.2%100% | 532−10.8%100% | 549−9.0%100% | 575−18.3%100% | 738−18.3%100% | 597−53.2%100% | 603—100% | 704—100% | 904—100% | 1,276—100% | |
| Accounts payable | 194—38.4% | 194+1.7%38.4% | 183+7.5%35.5% | 180+7.4%32.1% | 192−4.1%36.1% | 191+7.8%34.7% | 170−9.8%29.6% | 168−8.7%22.7% | 200+35.6%33.5% | 177—29.3% | 189—26.8% | 184—20.3% | 148—11.6% | |
| Current liabilities | 1,443—286% | 1,443+44.8%286% | 1,353+46.9%262% | 1,248+30.1%223% | 1,051+53.5%198% | 997+67.3%182% | 921+54.5%160% | 959+47.9%130% | 685+4.7%115% | 596—98.8% | 596—84.7% | 649—71.8% | 654—51.3% | |
| Total liabilities | 1,443—286% | 1,443+44.8%286% | 1,353+46.9%262% | 1,248+30.1%223% | 1,051+53.5%198% | 997+67.3%182% | 921+54.5%160% | 959+47.9%130% | 685+4.7%115% | 596—98.8% | 596—84.7% | 649—71.8% | 654—51.3% | |
| Retained earnings | −86,555—−17173% | −86,555—−17173% | −86,451—−16763% | −86,275—−15409% | −85,525—−16068% | −85,451—−15568% | −85,344—−14839% | −84,903—−11499% | −84,770—−14204% | −84,674—−14035% | −84,563—−12015% | −84,393—−9335% | −83,997—−6584% | |
| Shareholders' equity | −939—−186% | −939—−186% | −838—−162% | −688—−123% | −519—−97.5% | −448−6059%−81.6% | −346r−346−422%−60.2% | −221−187%−29.9% | −88−114%−14.8% | 7.5—1.2% | 107—15.3% | 255—28.2% | 622—48.7% | |
| Total liabilities and equity | 504—100% | 504−8.2%100% | 516−10.3%100% | 560−24.2%100% | 532−10.8%100% | 549−9.0%100% | 575−18.3%100% | 738−18.3%100% | 597−53.2%100% | 603—100% | 704—100% | 904—100% | 1,276—100% | |
| Shares outstanding | 148—— | 148+9.1%— | 148+9.1%— | 147+17.5%— | 136+10.1%— | 136+10.1%— | 136+10.1%— | 125+1.6%— | 1230.0%— | 123—— | 123—— | 123—— | 123—— | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | — | 5.4−3.3%— | 5.60.0%— | — | 8.2+45.6%— | 5.6−31.3%— | 5.6−1.7%— | 5.6*—— | 5.6−32.6%— | 8.2—— | 5.7—— | — | 8.3—— | |
| Share-based compensation | — | 0*—— | 0−100%— | — | — | 0*—— | 300—— | — | — | — | — | — | — | |
| Cash from operating activities | −201—— | −19*−1520%— | −58—— | −120*—— | −5.0*—— | 1.3*—— | −72—— | −127r−136*—— | −29r−20*—— | −82*—— | −178—— | −340*—— | −451*—— | |
| Capital expenditure | — | — | — | — | — | — | — | — | 0*—— | 0*—— | 0—— | 0*—— | 0*—— | |
| Cash from investing activities | — | — | — | — | — | — | — | — | 0*−100%— | 0*—— | 0—— | 0*—— | 1,641*—— | |
| Cash from financing activities | 200−8.4%— | 18*+800%— | 29—— | 152*−45.8%— | 0*−100%— | 2.0*—— | −84—— | 281r290*—— | 19r10*—— | −5.0*—— | −10—— | −15*—— | −530r−580*—— | |
| Exchange-rate effect on cash | — | 0*—— | −2.8—— | — | — | −1.1*—— | −0.1—— | — | — | — | — | — | — | |
| Change in cash | — | — | — | — | −5.0*—— | 3.3*—— | −156—— | 154*—— | −9.7*−102%— | −87*—— | −188—— | −355*—— | 610*—— | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q/A | 10-Q | 10-Q | 10-K | 10-Q/A | 10-Q | 10-Q | 10-K | 10-Q | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Jun 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
Events at Weed Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.
Directors and officers 1 · Material agreement 4 · Unregistered share sale 1
Source: SEC EDGAR, Form 8-K item numbers · as of Aug 4, 2022
Acquisitions and funding#
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Feb 2018 | $12 M | Private placement after listing | $10 to $50 million | 2 | equity | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
Peer comparison · Pharmaceutical
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Weed Inc.🇺🇸 | $9 M | — | — | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Amgen Inc.🇺🇸 | $249.2 B | 26.5× | 24.1% | +9.9% |
| AstraZeneca PLC🇬🇧 | $242.6 B | 23.7× | 17.4% | +8.6% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Eli Lilly and Company$1.20 T
- Johnson & Johnson$652.5 B
- AbbVie Inc.$514.0 B
- Roche Holding AG$370.3 B
- Merck & Co., Inc.$359.8 B
- Novartis AG$286.8 B
Sources and freshness
- Market cap:
- Jul 30, 2023 (last known)
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Profile updated:
- Nov 16, 2026
Figures from SEC filing, value.today research, SEC annual report; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Weed Inc.? Verify and update this profile — free
Show Weed Inc.'s ranking on your website Get the badge
The badge updates itself as the ranking changes.